FDA Inspection
Morton Drug Company dba Morton LTCMorton Drug Company dba Morton LTC – FDA Inspection, Dec 22, 2015
Record Details
This FDA Inspection record concerns Morton Drug Company dba Morton LTC, with an inspection on December 22, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 22, 2015
- Product Type
- Drugs
View Company Profile
ID · f14f1f51-e51c-4a2c-85b4-362b6e097f90
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 953460
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.42(c)(10)(vi)Equipment to control conditions
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.28(a)Protective Apparel Not Worn
- 21 CFR 211.166(a)Results not used for expiration dates, storage cond.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Morton Drug Company dba Morton LTC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 31, 2018 | Not classified | Minneapolis District Office | Drug Quality Assurance |
| May 20, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Morton Drug Company dba Morton LTC
- FDA Inspection 1064518 - 2018-08-31
- FDA Inspection 724709 - 2011-05-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.